updated results from a trial of trastuzumab deruxtecan for her2-positive breast cancer
Published 3 years ago • 49 plays • Length 6:07Download video MP4
Download video MP3
Similar videos
-
5:59
trastuzumab deruxtecan for the treatment of her2 breast cancer
-
4:01
trastuzumab deruxtecan: a promising agent for treating her2-low breast cancer?
-
1:08
destiny-breast04: a ground-breaking trial in her2-low breast cancer
-
5:25
asco: promising results for trastuzumab deruxtecan for her2 gastric cancer
-
0:46
clinical trials remain underway for trastuzumab deruxtecan in her2-positive breast cancer
-
1:29
tuxedo-1: trastuzumab deruxtecan for the treatment of her2-positive breast cancer brain metastases
-
4:35
a multi-histology basket trial of ado-trastuzumab emtansine in patients with her2 amplified cancers
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
2:06
antibody-drug conjugates for her2-low disease: 2023 ku breast cancer year in review
-
56:42
research update for her2-positive mbc | 2021-2022 embrace mbc virtual forum series
-
2:12
trastuzumab deruxtecan in her2-low advanced breast cancer | nejm
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
6:04
katherine trial updates for her2-positive breast cancer
-
5:40
trastuzumab deruxtecan doubles pfs in metastatic breast cancer with low her2 expression
-
2:31
results of the aphinity trial in her2-positive breast cancer
-
1:58
destiny-gastric02: t-dxd as a second-line treatment for her2-positive gastric cancer
-
7:32
trastuzumab deruxtecan yields promising results in her2-positive breast cancer patients pretreat...
-
5:26
trastuzumab deruxtecan shows benefit in patients with her2 mbc
-
1:14
updated analysis from mountaineer: tucatinib and trastuzumab for her2-positive mcrc